Association between proton pump inhibitors and periodontal disease severity
Abstract Objectives Proton pump inhibitors (PPIs) are commonly prescribed for the management of acid‐related gastrointestinal disorders. PPIs modulate osteoclast function, reduce gastric acid secretion, and are associated with the establishment of a more diverse gastrointestinal microbiota. Periodon...
Saved in:
Main Authors: | Bhavneet K. Chawla (Author), Robert E. Cohen (Author), Lisa M. Yerke (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2022-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The influence of proton pump inhibitors on tissue attachment around teeth and dental implants: A scoping review
by: Bhavneet K. Chawla, et al.
Published: (2022) -
Proton-pump inhibitors and risk of renal disease
by: Mahrang Hedaiaty, et al.
Published: (2017) -
Is hypomagnesemia associated with using proton pump inhibitors?
by: Joo-Hark Yi, et al.
Published: (2016) -
Proton-pump inhibitor use amongst patients with severe hypomagnesemia
by: Sherry Seah, et al.
Published: (2023) -
RENAL SAFETY OF PROTON PUMP INHIBITORS
by: A. I. Dyadyk, et al.
Published: (2017)